+499.5%
MRNA vs BG
+50.1%
+449.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.1% | -2.4% |
| 7D | +5.5% | +2.8% | +2.7% | +5.9% |
| 30D | +158.7% | +12.0% | +146.7% | +160.8% |
| 3M | +182.1% | -7.7% | +189.8% | +189.3% |
| 6M | +151.8% | +4.5% | +147.3% | +150.5% |
| YTD | +393.6% | +35.7% | +357.9% | +363.9% |
| 1Y | +499.5% | +50.1% | +449.4% | +441.4% |
| All | +499.5% | +50.1% | +449.4% | +441.4% |
Cumulative growth
Daily Returns
Daily percentage return beside BG.
Daily Out/Under-Performance
Portfolio return minus BG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling